Skip to main content

Table 2 Quality assessment of the case–control studies using the Newcastle Ottawa scale

From: Pro- and anti-inflammatory cytokines and osteoclastogenesis-related factors in peri-implant diseases: systematic review and meta-analysis

Autor

Year

Criterion Scores

Total score

Selection

Comparability

Exposure

Arikan

2011

1–2-3–4

1–2

1–2-3

9—high quality

Casado

2013

1–4

1–2

1–2-3

7—high quality

Duarte

2009

1–2-4

1–2

1–2-3

8—high quality

Fonseca

2012

1–2-3–4

1–2

1–2-3

9—high quality

Ghigh

2017

1–2-4

1–2

1–2-3

8—high quality

Guncu

2012

1–3-4

1–2

1–2-3

8—high quality

Rakic

2015

1–2-3–4

1–2

1–2-3

9—high quality

Rakic

2020

1–2-3–4

1–2

1–2-3

9—high quality

Severino

2011

1–2-3–4

1–2

1–2-3

9—high quality

Severino

2016

1–2-3–4

1–2

1–2-3

9—high quality

Teixeira

2016

1–4

1–2

1–2-3

7—high quality

Yakar

2018

1–2-3–4

1–2

1–2-3

9—high quality

  1. Selection: 1. Is the Case Definition Adequate? Yes, with independent validation; 2. Representativeness of the Cases: Consecutive or Obviously Representative Series of Cases; 3. Selection of Controls: Community Controls; 4. Definition of Controls: No History of Disease (endpoint); Comparability: 1. Study Controls for smoke; 2. Study Controls for systemic disease; Exposure: 1. Ascertainment of Exposure: Secure Record; 2. The same method of: Yes; 3. Nonresponse rate: same rate for both groups